
Etomidate use during the initiation of invasive mechanical ventilation (IMV) is associated with higher hospital mortality compared to ketamine. In a study of over 1.6 million ICU patients, those receiving etomidate had a 2.8% higher mortality risk than those receiving ketamine, regardless of subsequent corticosteroid treatment. This suggests that etomidate, though commonly used, may carry a higher risk of mortality in critically ill patients.
Like
Save
Share